Health and Fitness Health and Fitness
Tue, August 2, 2011
Mon, August 1, 2011
Sun, July 31, 2011
Fri, July 29, 2011
Thu, July 28, 2011
Wed, July 27, 2011
[ Wed, Jul 27th 2011 ] - Market Wire
00 AM EDT
Tue, July 26, 2011
Mon, July 25, 2011
Sat, July 23, 2011
Fri, July 22, 2011
Thu, July 21, 2011
Wed, July 20, 2011
[ Wed, Jul 20th 2011 ] - Market Wire
Pfizer To Acquire Icagen
[ Wed, Jul 20th 2011 ] - Market Wire
00 a.m. EDT
Tue, July 19, 2011
Mon, July 18, 2011
[ Mon, Jul 18th 2011 ] - Market Wire
Aetna to Acquire PayFlex
Fri, July 15, 2011
Thu, July 14, 2011
Wed, July 13, 2011
Tue, July 12, 2011
Mon, July 11, 2011
Sun, July 10, 2011
Sat, July 9, 2011
Fri, July 8, 2011

Law Firm Brower Piven Announces Investigation of Icagen, Inc.


//health-fitness.news-articles.net/content/2011/ .. piven-announces-investigation-of-icagen-inc.html
Published in Health and Fitness on Wednesday, July 20th 2011 at 7:46 GMT by Market Wire   Print publication without navigation


STEVENSON, Md.--([ BUSINESS WIRE ])--The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Icagen, Inc. (aIcagena) (NASDAQ: ICGN) and other violations of state law by the Board of Directors of Icagen relating to the proposed acquisition of the company by Pfizer Inc. (aPfizera) (NYSE: PFE). The firma™s investigation seeks to determine whether Icagena™s Board breached their fiduciary duties by, among other things, failing to maximize shareholder value.

On July 20, 2011, Icagen and Pfizer jointly announced that they have entered into a definitive merger agreement for Pfizer, which currently owns approximately 11% of Icagena™s fully diluted shares, to acquire the remaining 8.3 million shares at a price of $6.00 per share. The press release states that the aggregate transaction value, including the value of the shares currently owned by Pfizer, is approximately $56 million. Under the terms of the definitive merger agreement, Pfizer will promptly commence a tender offer to purchase all of the outstanding shares of Icagen common stock for $6.00 per share in cash. While there has been some news of a potential acquisition of Icagen by Pfizer since the end of June 2011, the tender offer price represents a 23% discount to the prior closing price. Indeed, in a recent quarterly earnings conference call, Icagen announced avery positivea financial results for 2010 and that it was in avery solid shape going into 2011,a with at least one analyst setting a target price of $8.00 per share.

If you own Icagen common stock and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at [ hoffman@browerpiven.com ], by calling 410/415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.


Publication Contributing Sources